Related references
Note: Only part of the references are listed.Serine Metabolism Supports Macrophage IL-1β Production
Arianne E. Rodriguez et al.
CELL METABOLISM (2019)
Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E
Xuhui Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma
Y. Qin et al.
LEUKEMIA (2017)
Modulating the therapeutic response of tumours to dietary serine and glycine starvation
Oliver D. K. Maddocks et al.
NATURE (2017)
Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
Ming Wu et al.
ONCOTARGETS AND THERAPY (2017)
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis
Boxi Zhang et al.
CELL REPORTS (2017)
Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
Esther A. Zaal et al.
CANCER & METABOLISM (2017)
Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth
Florence Polet et al.
ONCOTARGET (2016)
NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells
Cheng Zeng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
The importance of serine metabolism in cancer
Katherine R. Mattaini et al.
JOURNAL OF CELL BIOLOGY (2016)
Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
G. P. Soriano et al.
LEUKEMIA (2016)
Comprehensive Identification of RNA-Binding Domains in Human Cells
Alfredo Castello et al.
MOLECULAR CELL (2016)
A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
Michael E. Pacold et al.
NATURE CHEMICAL BIOLOGY (2016)
Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
Edouard Mullarky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
K. K. Starheim et al.
BLOOD CANCER JOURNAL (2016)
Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
Patricia Maiso et al.
CANCER RESEARCH (2015)
NRF2 regulates serine biosynthesis in non-small cell lung cancer
Gina M. DeNicola et al.
NATURE GENETICS (2015)
p53 Protein-mediated Regulation of Phosphoglycerate Dehydrogenase (PHGDH) Is Crucial for the Apoptotic Response upon Serine Starvation
Yang Ou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Neu-Laxova Syndrome Is a Heterogeneous Metabolic Disorder Caused by Defects in Enzymes of the L-Serine Biosynthesis Pathway
Rocio Acuna-Hidalgo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death
Li Yin et al.
BLOOD (2014)
ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma
W. Zhou et al.
LEUKEMIA (2014)
NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
Wen Zhou et al.
CANCER CELL (2013)
Metabonomics Identifies Serum Metabolite Markers of Colorectal Cancer
Binbin Tan et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Metabolic targets for cancer therapy
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Novel Agents for Multiple Myeloma to Overcome Resistance in Phase III Clinical Trials
Robert Z. Orlowski
SEMINARS IN ONCOLOGY (2013)
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Zaynab Al-Eisawi et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Serum Metabolic Signatures of Fulminant Type 1 Diabetes
Jingyi Lu et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis
Sirkku Pollari et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Serine Metabolism: Some Tumors Take the Road Less Traveled
Ralph J. DeBerardinis
CELL METABOLISM (2011)
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato et al.
NATURE (2011)
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Jason W. Locasale et al.
NATURE GENETICS (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells
Hongjuan Dong et al.
LEUKEMIA & LYMPHOMA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Endoplasmic reticulum stress and oxidative stress: A vicious cycle or a double-edged sword?
Jyoti D. Malhotra et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage
Rentian Feng et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
P Perez-Galan et al.
BLOOD (2006)
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors
XY Pei et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
